PT  - JOURNAL ARTICLE
AU  - Di Maria, Emilio
AU  - Gualco, Carlotta
AU  - Muscolino, Erika
AU  - Reale, Nicoletta
AU  - Solaro, Claudio Marcello
AU  - Camia, Laura
AU  - Tortorolo, Umberto
AU  - Ivaldi, Claudio
AU  - Mazzella, Luca
AU  - Bandini, Fabio
AU  - Maioli, Elia
AU  - Stella, Manuela
AU  - Mattioli, Francesca
AU  - Zumerle, Erika
AU  - Flego, Gaddo
AU  - Mazzocco, Michela
AU  - Sacchi, Nicoletta
AU  - Schenone, Angelo
AU  - Tettamanti, Mauro
AU  - Marcon, Gabriella
AU - The COOL study Investigators
AU  - Del Sette, Massimo
TI  - Centenarians and Oldest Olds in Liguria – COOL: a multidisciplinary study to investigate the genetic determinants of cognitive well-being in Genoa, Italy. Rationale, study protocol and cohort profile
AID  - 10.64898/2026.05.20.26353506
DP  - 2026 Jan 01
TA  - medRxiv
PG  - 2026.05.20.26353506
4099  - http://medrxiv.org/content/early/2026/05/28/2026.05.20.26353506.short
4100  - http://medrxiv.org/content/early/2026/05/28/2026.05.20.26353506.full
AB  - Objectives Despite the body of literature on genetic risk factors for dementia, little is known on protective genetic factors associated with favourable cognitive ageing in the oldest population. In Europe, Italy has a leading position with a swelling population of centenarians, and the urban area of Genoa in the Liguria region has one of the highest prevalence of centenarians. The COOL study is a not-for-profit, multicentric study involving a cohort of centenarians (aged >99) living in the Genoa area. The ultimate aim is the identification of genomic biomarkers associated with cognition in the oldest old population.Results Participants underwent a semi-structured interview on personal, disease and family history, and a neuropsychological assessment of the main cognitive domains. As of July 2025, we enrolled 88 centenarians (age range: 99-108, median 100.56) with and without cognitive impairment; 32 subjects were followed up. All participants were of Italian ancestry, 81% were female. The cognitive profile in assessed subjects showed a wide range of cognitive health measures (CDR 0-5; MMSE 3-30, median 24). Whole peripheral blood and DNA samples from 67 participants were stored.Conclusions We demonstrated that the protocol is feasible, and acceptable by participants and their families. A comprehensive phenotype dataset was established, and DNA samples were stored. Centenarians exhibited a broad spectrum of cognitive profiles, from preserved cognition to severe dementia. These findings will eventually allow to interpret the profiles of genomic variants as associated with variability of cognitive performance in centenarians. The molecular underpinnings of healthy cognitive ageing could inform health policy strategies in the general population.The study protocol was feasible and well-accepted by centenarians and their families.A comprehensive phenotype dataset was established, and DNA samples were collected and stored.Centenarians exhibited a broad spectrum of cognitive profiles, from preserved cognition to severe dementia.Genomic profiling will eventually enable the investigation of genetic variability underlying cognitive health.Missing data were present, consistent with the study design and the characteristics of the extremely aged cohort.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe COOL project was partially funded by the Galliera Hospital (EO Ospedali Galliera, fondo Sper 41). EM is a fellow of the Department of Health Sciences, University of Genoa, supported by the fund 'donazioni per ricerca scientifica su coronavirus', University of Genoa.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Local Ethics Committee (Comitato Etico Territoriale, Regione Liguria, approval ID CER Liguria 91/2021).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.University of Genoa, https://ror.org/0107c5v14, fund “donazioni per ricerca scientifica su coronavirus”, Department of Health SciencesEnte Ospedaliero Ospedali Galliera, https://ror.org/05bs6ak67, fondo Sper 41